Inhibition of TRIM32 by ibr‐7 treatment sensitizes pancreatic cancer cells to gemcitabine via mTOR/p70S6K pathway

Pancreatic cancer is one of the most notorious diseases for being asymptomatic at early stage and high mortality rate thereafter. However, either chemotherapy or targeted therapy has rarely achieved success in recent clinical trials for pancreatic cancer. Novel therapeutic regimens or agents are urg...

Descripción completa

Detalles Bibliográficos
Autores principales: Zhang, Bo, Yan, You‐you, Gu, Yang‐qin, Teng, Fei, Lin, Xu, Zhou, Xing‐lu, Che, Jin‐xin, Dong, Xiao‐wu, Zhou, Li‐xin, Lin, Neng‐ming
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2021
Materias:
Original Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8743670/
https://www.ncbi.nlm.nih.gov/pubmed/34921503
http://dx.doi.org/10.1111/jcmm.17109

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8743670/
https://www.ncbi.nlm.nih.gov/pubmed/34921503
http://dx.doi.org/10.1111/jcmm.17109

Ejemplares similares